| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |